Alan Meds vs Teleios Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Teleios Health
Best for Buyers comparison-shopping among cash-pay compounded-semaglutide ($99/mo floor) and compounded-tirzepatide ($139/mo floor) telehealth platforms and willing to contact the operator directly to confirm state availability, pharmacy partner, lab requirements, and refund policy before purchase.Starting at $99/mo
Side-by-Side Comparison
| Feature | Alan Meds | Teleios Health |
|---|---|---|
| Overall Score | ✓7.7/10 | 5.0/10 |
| Starting Price | $99/mo | $99/mo |
| Editorial Rating | ✓3.9 ★ /5 | 2.5 ★ /5 |
| Features | 5 features | ✓6 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Teleios Health
Pros
- ✓Lowest published compounded-semaglutide floor price tier in the cash-pay segment at $99/mo (per Open Graph + page-title meta; floor only — maintenance dose pricing not surfaced publicly)
- ✓Compounded-tirzepatide also offered at a competitive $139/mo floor
- ✓Explicitly markets physician (MD/DO) prescribing rather than NP-only model
- ✓Clean meta-tag and Open Graph implementation — the operator clearly invests in marketing attribution and SEO basics
Cons
- ✗Single-page React app: state availability, pharmacy partner, dose-tier pricing ladder, lab requirements, refund/cancellation policy, and BMI eligibility are NOT visible in static HTML and could not be live-verified
- ✗No named medical director, founder, physician, or corporate entity disclosed in the static site meta
- ✗Year founded NOT_VERIFIED — newer entrants in this floor-price band warrant elevated KYC scrutiny
- ✗No LegitScript / NABP / SOC 2 trust-signal claim surfaced in the static markup reviewed
- ✗Ad-tech stack (Myosin CAPI + Google Tag Manager) is consistent with a paid-acquisition-led growth model — not a knock by itself, but worth pairing with elevated diligence on the clinical layer before purchase
- ✗Floor-only pricing transparency: 'from $99/mo' / 'from $139/mo' framing does not surface the maintenance-dose ceiling that buyers will actually pay
Our Verdict
Alan Meds edges out Teleios Health with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Teleios Health remains a solid alternative, especially if you're looking for Buyers comparison-shopping among cash-pay compounded-semaglutide ($99/mo floor) and compounded-tirzepatide ($139/mo floor) telehealth platforms and willing to contact the operator directly to confirm state availability, pharmacy partner, lab requirements, and refund policy before purchase..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Alan Meds and Teleios Health head-to-heads in the same category.
- Alan Meds vs CoreAge Rx
- Alan Meds vs TrimRx
- Alan Meds vs Amazon One Medical
- Teleios Health vs NovoCare Pharmacy
- Teleios Health vs Vytora Health
- Teleios Health vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.